A detailed history of General Partner, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, General Partner, Inc. holds 11,935 shares of JNJ stock, worth $1.75 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
11,935
Previous 14,935 20.09%
Holding current value
$1.75 Million
Previous $2.18 Billion 11.39%
% of portfolio
1.2%
Previous 1.39%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

SELL
$145.48 - $167.38 $436,439 - $502,140
-3,000 Reduced 20.09%
11,935 $1.93 Billion
Q2 2024

Jul 05, 2024

SELL
$144.38 - $157.78 $91,248 - $99,716
-632 Reduced 4.06%
14,935 $2.18 Billion
Q4 2023

Jan 08, 2024

SELL
$145.6 - $158.88 $366,038 - $399,424
-2,514 Reduced 13.9%
15,567 $2.48 Billion
Q1 2023

Apr 07, 2023

BUY
$151.05 - $180.26 $10,120 - $12,077
67 Added 0.37%
18,081 $2.95 Billion
Q4 2022

Jan 05, 2023

BUY
$160.2 - $179.79 $2.89 Million - $3.24 Million
18,014 New
18,014 $3.18 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track General Partner, Inc. Portfolio

Follow General Partner, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of General Partner, Inc., based on Form 13F filings with the SEC.

News

Stay updated on General Partner, Inc. with notifications on news.